Aurinia Pharmaceuticals Inc (AUPH)

Operating Income Growth

189.85%

TTM · Period ending:

AUPH logo

AUPH Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported189.85%
AUPH TTM Operating Income YoY % (-453.81% → 189.85%)
High-resolution chart · PNG

AUPH operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
189.8479%
309.3282%
5,027.8535%
332.3157%
189.4471%
141.775%
97.6781%
66.5612%
30.2425%
29.4363%
17.7438%
22.3631%
46.8849%
38.6151%
38.3241%
25.632%
-6.0016%
-31.5411%
-73.3004%
-33.2463%
-49.7906%
-44.4987%
-36.7738%
-67.3089%
-64.4219%
-52.4674%
-35.7776%
-30.5385%
-12.7429%
-18.2988%
-19.3252%
-24.8783%
-54.32%
-68.7491%
-106.29%
-111.436%
-61.8144%
-27.1367%
3.2485%
11.2853%
-3.2497%
-19.0466%
-35.9705%
-65.3251%
-94.0316%
-174.5106%
-324.4049%
-65.2402%
-17.7067%
30.5047%
25.1109%
-397.3612%
-721.0329%
-815.9836%
18.3248%
75.5827%
84.6849%
81.4057%
-32.4416%
-48.0974%
-43.9708%
11.9482%
39.7277%
47.3416%
53.9742%
52.4748%
49.9271%
62.5765%
61.2461%
56.2041%
51.02%
23.9922%
5.3608%
-23.7034%
-42.9655%
-13.928%
-12.6427%
3.7537%
19.1193%
4.7272%
11.3538%
-1.3974%
-29.5085%
-47.842%
-76.0821%
-140.6767%
-108.6437%
-122.8145%
-495.6924%
-381.5939%
-663.7233%
-1,712.5324%
48.2473%
77.041%
95.3332%
43.971%
-21.7875%
-117.6085%
-206.5558%
-344.3402%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.